Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study.
about
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus Recommendations for Subsequent NeoplasmsProgression of Common Variable Immunodeficiency Interstitial Lung Disease Accompanies Distinct Pulmonary and Laboratory Findings.Adherence to cancer screening guidelines in Australian survivors of allogeneic blood and marrow transplantation (BMT).Mouth cancer in inflammatory bowel diseases.Autoimmune and Lymphoproliferative Complications of Common Variable Immunodeficiency.Lung Disease in Primary Antibody Deficiencies.
P2860
Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Use of azathioprine for graft- ...... onwide population-based study.
@ast
Use of azathioprine for graft- ...... onwide population-based study.
@en
type
label
Use of azathioprine for graft- ...... onwide population-based study.
@ast
Use of azathioprine for graft- ...... onwide population-based study.
@en
prefLabel
Use of azathioprine for graft- ...... onwide population-based study.
@ast
Use of azathioprine for graft- ...... onwide population-based study.
@en
P2093
P2860
P356
P1476
Use of azathioprine for graft- ...... onwide population-based study.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2014.523
P407
P577
2014-10-14T00:00:00Z